The Ultimate End Of Life / Palliative care Quiz

Increased appetite is not a sign that death may be near. In fact, it is quite the opposite. When death is approaching, a person's appetite usually decreases or they may lose interest in eating altogether. This can be due to various factors such as the body shutting down, decreased metabolism, or changes in the person's overall condition. Therefore, increased appetite is not typically associated with the end of life.

In end-of-life care, pain can be managed through the administration of morphine. Morphine is a powerful opioid analgesic that is commonly used to alleviate severe pain. It works by binding to opioid receptors in the brain and spinal cord, blocking the transmission of pain signals and providing relief. Morphine is often prescribed in end-of-life care to help patients manage pain and improve their quality of life. It is important to carefully monitor the dosage and side effects of morphine to ensure optimal pain management and patient comfort.

Dyspnea is the medical term for breathlessness or difficulty in breathing. It is a symptom commonly associated with various respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and heart failure. It can also be caused by anxiety, panic attacks, and physical exertion. Agitation, fever, and nausea are not directly related to breathlessness.

Benzodiazepines are a class of medications that are commonly used to treat anxiety and agitation. They work by enhancing the effects of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain, which helps to reduce feelings of anxiety and promote relaxation. Therefore, it can be inferred that the use of benzodiazepines is specifically controlled and targeted towards managing agitation.

The United Kingdom ranked highest globally in the study of end-of-life care in 2015. This means that the United Kingdom was considered to have the best quality of care for individuals nearing the end of their lives compared to other countries. The study likely evaluated factors such as access to palliative care, pain management, support for patients and their families, and overall quality of end-of-life services.

Helping the sick walk around is not considered an end-of-life care because it implies that the person is still able to move and requires assistance for mobility. End-of-life care typically focuses on providing comfort and support to individuals who are terminally ill and may not have the physical ability to walk or perform daily activities. Therefore, the act of helping the sick walk around does not align with the concept of end-of-life care.

Respiratory tract infections are not typically associated with agitation in end-of-life care patients. Agitation is commonly seen in patients experiencing restlessness, delirium, and terminal anguish. Respiratory tract infections may cause physical discomfort and distress, but they do not directly contribute to agitation in these patients.

Oral administration can be assisted for such patients because it is a convenient and non-invasive route of drug administration. It involves taking medication through the mouth, either in the form of tablets, capsules, or liquids, which can be easily swallowed. This route is suitable for patients who have difficulty swallowing or are unable to receive medication through other routes such as injections. Additionally, oral administration allows for slow and controlled release of the drug into the bloodstream, making it an effective and commonly used route of administration.

The end of life care programme was established in the UK in 2004.

The national strategy document for palliative care was published in the UK in 2008.